Senhwa announces multiple IND application submissions to US FDA and Health Canada evaluating its investigational drug, CX-5461, for the treatment of patients with solid ... Nov 26
The company is encouraged by the patient's strong response to Silmitasertib and will make every effort to provide the drug to critically ill COVID-... Sep 12
-Advertisements-